Eli Lilly Seeks Emergency Use Authorization for Its COVID-19 Antibody Treatment

<p>More good news on treatments for COVID-19. Pharmaceutical company Eli Lilly, has requested the emergency use authorization of its antibody- based treatment for people with mild to moderate symptoms of coronavirus. This treatment is similar to the one that President Trump received and they could have 100,000 doses ready this month and one million by the end of the year. Peter Loftus, health care reporter at the WSJ, joins us for more.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>